These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 286110)

  • 21. Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
    Herberman RB; Hollinshead AC; Alford TC; McCoy JL; Halterman RH; Leventhal BG
    Natl Cancer Inst Monogr; 1973 Jun; 37():189-95. PubMed ID: 4123453
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunology of malignant melanoma].
    Misgeld V
    Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical studies on the reaction of the skin to various doses of Su-polysaccharide in cancer patients].
    Sato M; Sakai K; Kimura S; Tamaki Y; Kiyasu Y; Joko Y; Ogoshi T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):245-9. PubMed ID: 3970550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
    Kokoschka EM; Micksche M
    Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.
    Morris DL; Hersh EM; Hsi BP; Gutterman JU; Marshall MM; Mavligit GM
    Cancer Res; 1979 Jan; 39(1):219-26. PubMed ID: 761192
    [No Abstract]   [Full Text] [Related]  

  • 27. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed cutaneous hypersensitivity reactions to concanavalin A-binding tumour membrane components.
    Cunningham TJ; Weber PB; Teitelbaum HD; Blumenstock FA; Charniga C
    Clin Exp Immunol; 1975 Jul; 21(1):97-100. PubMed ID: 1181077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity in breast cancer.
    Roberts MM; Williams WJ
    Br J Surg; 1968 Nov; 55(11):869. PubMed ID: 5687020
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dermal reactions to melanoma autohomogenates].
    Tritsch H
    Hautarzt; 1970 Jun; 21(6):258-65. PubMed ID: 5520644
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed cutaneous hypersensitivity reaction in breast cancer patients.
    Jain P; Khanna NN
    J Indian Med Assoc; 1988 Jan; 86(1):5-7. PubMed ID: 3288701
    [No Abstract]   [Full Text] [Related]  

  • 32. [Delayed hypersensitivity reactions in cancer patients: influence of the clinical stage and chemo- and radiotherapy on the immune status].
    Bouckenaere-Wojcik D; Delzenne G; Deckers C
    Bull Cancer; 1982; 69(5):468-75. PubMed ID: 7165809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival.
    Stewart TH; Orizaga M
    Cancer; 1971 Dec; 28(6):1472-8. PubMed ID: 5127795
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Melanoma of the uvea, cancer of the eye and immune phenomena].
    Vérin P; Gendre P; Meunier J
    Arch Ophtalmol Rev Gen Ophtalmol; 1972; 32():Suppl 1:21-8. PubMed ID: 4262497
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer.
    Boddie AW; Holmes EC; Roth JA
    Surg Forum; 1974; 25(0):109-10. PubMed ID: 4439134
    [No Abstract]   [Full Text] [Related]  

  • 37. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
    Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
    Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic responses in cancer patients.
    Solowey AC; Rapaport FT
    Surg Gynecol Obstet; 1965 Oct; 121(4):756-60. PubMed ID: 5838283
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspects of immunology in radiotherapy.
    James KW
    Mod Trends Radiother; 1972; 2():77-97. PubMed ID: 4563804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.